ID: ALA219510

Max Phase: Preclinical

Molecular Formula: C27H27N3O4

Molecular Weight: 457.53

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cn(CCOCCOC(c2ccccc2)(c2ccccc2)c2ccncc2)c(=O)[nH]c1=O

Standard InChI:  InChI=1S/C27H27N3O4/c1-21-20-30(26(32)29-25(21)31)16-17-33-18-19-34-27(22-8-4-2-5-9-22,23-10-6-3-7-11-23)24-12-14-28-15-13-24/h2-15,20H,16-19H2,1H3,(H,29,31,32)

Standard InChI Key:  FALXHDVQJVMXGK-UHFFFAOYSA-N

Associated Targets(Human)

Thymidine kinase, mitochondrial 96 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Thymidine kinase 140 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Deoxynucleoside kinase 95 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 457.53Molecular Weight (Monoisotopic): 457.2002AlogP: 3.27#Rotatable Bonds: 10
Polar Surface Area: 86.21Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 10.01CX Basic pKa: 4.96CX LogP: 3.61CX LogD: 3.61
Aromatic Rings: 4Heavy Atoms: 34QED Weighted: 0.37Np Likeness Score: -0.78

References

1. Hernandez AI, Familiar O, Negri A, Rodríguez-Barrios F, Gago F, Karlsson A, Camarasa MJ, Balzarini J, Pérez-Pérez MJ..  (2006)  N1-substituted thymine derivatives as mitochondrial thymidine kinase (TK-2) inhibitors.,  49  (26): [PMID:17181158] [10.1021/jm0610550]

Source